A detailed history of Nuveen Asset Management, LLC transactions in Xencor Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 151,525 shares of XNCR stock, worth $3.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
151,525
Previous 177,773 14.76%
Holding current value
$3.79 Million
Previous $3.37 Million 9.45%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $412,093 - $568,269
-26,248 Reduced 14.76%
151,525 $3.05 Million
Q2 2024

Aug 09, 2024

BUY
$18.21 - $24.5 $477,976 - $643,076
26,248 Added 17.32%
177,773 $3.37 Million
Q1 2024

May 13, 2024

SELL
$18.65 - $26.52 $275,814 - $392,204
-14,789 Reduced 8.89%
151,525 $3.35 Million
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $83,195 - $107,806
5,033 Added 3.12%
166,314 $3.53 Million
Q3 2023

Nov 14, 2023

SELL
$20.08 - $25.39 $1.06 Million - $1.34 Million
-52,730 Reduced 24.64%
161,281 $3.25 Million
Q2 2023

Aug 14, 2023

BUY
$24.77 - $29.9 $822,537 - $992,889
33,207 Added 18.37%
214,011 $5.34 Million
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $487,652 - $694,364
-18,792 Reduced 9.42%
180,804 $5.04 Million
Q4 2022

Feb 14, 2023

SELL
$24.79 - $30.86 $688,864 - $857,537
-27,788 Reduced 12.22%
199,596 $5.2 Million
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $422,208 - $556,313
17,149 Added 8.16%
227,384 $5.91 Million
Q2 2022

Aug 15, 2022

BUY
$19.74 - $29.01 $870,849 - $1.28 Million
44,116 Added 26.56%
210,235 $5.75 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $55,174 - $86,090
2,068 Added 1.26%
166,119 $4.71 Million
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $481,413 - $621,105
-14,298 Reduced 8.02%
164,051 $5.55 Million
Q3 2021

Nov 12, 2021

SELL
$30.65 - $35.68 $1.02 Million - $1.19 Million
-33,366 Reduced 15.76%
178,349 $6.17 Million
Q2 2021

Aug 16, 2021

SELL
$34.33 - $44.68 $452,469 - $588,882
-13,180 Reduced 5.86%
211,715 $7.3 Million
Q1 2021

May 17, 2021

SELL
$40.81 - $53.88 $1.31 Million - $1.73 Million
-32,102 Reduced 12.49%
224,895 $9.68 Million
Q4 2020

Feb 16, 2021

SELL
$36.63 - $47.63 $1.54 Million - $2 Million
-41,933 Reduced 14.03%
256,997 $11.2 Million
Q3 2020

Nov 16, 2020

SELL
$30.09 - $43.02 $119,848 - $171,348
-3,983 Reduced 1.31%
298,930 $11.6 Million
Q2 2020

Aug 14, 2020

BUY
$27.76 - $33.42 $1.16 Million - $1.4 Million
41,920 Added 16.06%
302,913 $9.81 Million
Q1 2020

May 14, 2020

BUY
$20.69 - $37.79 $254,031 - $463,985
12,278 Added 4.94%
260,993 $7.8 Million
Q4 2019

Feb 14, 2020

SELL
$32.75 - $41.43 $146,130 - $184,860
-4,462 Reduced 1.76%
248,715 $8.55 Million
Q3 2019

Nov 14, 2019

SELL
$33.73 - $46.27 $585,687 - $803,432
-17,364 Reduced 6.42%
253,177 $8.54 Million
Q2 2019

Aug 15, 2019

BUY
$29.6 - $40.93 $8.01 Million - $11.1 Million
270,541 New
270,541 $11.1 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.